spacer
home > pmps > autumn 2003 > generics boards surfing the new wave in contract manufacturing services
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Generics Boards Surfing the New Wave in Contract Manufacturing Services

With the rapidly rising tide in sales of unbranded medicines, are the holders of expiring patents for branded products about to find themselves stranded on the rocks or simply getting wet feet?

Recent developments at the WTO and changes in Europe's pharmaceutical legislation could drive suppliers of generics to outsource development and production to countries like Portugal, where they can take the necessary steps before the tide turns for their branded or innovator competition.

With about 35 per cent of pharma's lucrative blockbusters coming off patent by 2007, the rising tide of generics will experience a big surge driving the managerial boards of generics suppliers to get to market as early as possible, preferably as soon as the bell-buoy rings 'time up'.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Dr Patricia Lobo, Editor of PMPS and Associate Director at Technomark Consulting Services Limited

Patricia Lobo PhD, Associate Director and Senior Consultant at Technomark Consulting Services Ltd, is the Editor of Pharmaceutical Manufacturing and Packing Sourcer (PMPS) published by Samedan Ltd. Patricia has worked for over 25 years in the pharmaceutical industry in quality control, clinical research, marketing and business development. Since she joined Technomark in 1992, Patricia has developed considerable expertise and a first class reputation in the core business of outsourcing clinical trials, and in contract manufacturing and packaging, providing in-depth market reports and strategic planning advice to a wide range of pharma and biotech companies.

spacer
Dr Patricia Lobo
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

MedPharm’s CSO and University of Reading Professor co-author new book on dermal formulation development

MedPharm’s Chief Scientific Officer and Co-Founder, Professor Marc Brown and University of Reading’s Professor Adrian Williams have co-authored the new book: ‘The Art and Science of Dermal Formulation Development”. It is the latest addition to ‘Drugs and the Pharmaceutical Sciences’, a series of textbooks and monographs published by CRC Press.
More info >>

White Papers

Clinical Trial-Specific Travel Programs as a Patient Retention Tool

For many patients, participating in a clinical trial is a major endeavor. Depending on the protocol requirements, study visits can be exhausting. There are a number of reasons why a patient may choose to participate in a trial only to drop out. Conversely, there are several approaches to proactively try to prevent this from happening. There are various methods professionals implement for patient retention. This white paper explores patient travel services as one patient retention strategy.
More info >>

 
Industry Events

The Universe of Pre-filled Syringes and Injection Devices

22-23 October 2019, The Swedish Exhibition & Congress Centre Gothia Towers Hotel

PDA’s Universe of Pre-filled Syringes and Injection Devices has become the must-attend meeting for everyone working in the field, and is now the world’s largest conference on this subject
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement